CSS
ADPT icon

Cubist Systematic Strategies’s Adaptive Biotechnologies ADPT Stock Holding History

Cubist Systematic Strategies’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.34M Sell
290,088
-168,783
-37% -$2.06M 0.02% 1049
2025
Q2 		$5.35M Buy
+458,871
New +$4.17M 0.02% 980
2025
Q1 		– Sell
-315,098
Closed -$1.89M – 2801
2024
Q4 		$1.89M Buy
315,098
+15,817
+5% +$87.2K 0.01% 1395
2024
Q3 		$1.53M Buy
+299,281
New +$1.3M 0.01% 1576
2024
Q2 		– Sell
-50,502
Closed -$162K – 2883
2024
Q1 		$162K Sell
50,502
-37,981
-43% -$147K ﹤0.01% 3155
2023
Q4 		$434K Buy
+88,483
New +$404K ﹤0.01% 2593
2023
Q2 		– Sell
-194,705
Closed -$1.72M – 3419
2023
Q1 		$1.72M Sell
194,705
-397,982
-67% -$3.51M 0.01% 1776
2022
Q4 		$4.53M Buy
592,687
+110,378
+23% +$859K 0.03% 1107
2022
Q3 		$3.43M Buy
482,309
+164,982
+52% +$1.55M 0.02% 1438
2022
Q2 		$2.57M Buy
317,327
+7,477
+2% +$65.7K 0.02% 1617
2022
Q1 		$4.3M Buy
309,850
+221,235
+250% +$3.48M 0.04% 847
2021
Q4 		$2.49M Buy
88,615
+46,082
+108% +$1.41M 0.02% 1188
2021
Q3 		$1.45M Buy
42,533
+17,823
+72% +$645K 0.02% 1251
2021
Q2 		$1.01M Sell
24,710
-59,054
-71% -$2.3M 0.01% 1568
2021
Q1 		$3.37M Buy
83,764
+77,844
+1,315% +$4.21M 0.04% 676
2020
Q4 		$350K Buy
5,920
+2,637
+80% +$136K ﹤0.01% 1962
2020
Q3 		$160K Buy
3,283
+83
+3% +$3.49K ﹤0.01% 2190
2020
Q2 		$155K Sell
3,200
-20,362
-86% -$742K ﹤0.01% 2111
2020
Q1 		$655K Buy
+23,562
New +$657K 0.02% 1091

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's ADPT Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Adaptive Biotechnologies (ADPT) stake by 37% in Q3 2025, selling an estimated $2.06M and leaving 290,088 shares worth $4.34M. The position accounts for 0.02% of the portfolio, ranked #1049.

Cubist Systematic Strategies first reported a position in ADPT in Q1 2020 and has held it in 19 quarters since. The position peaked at $5.35M in Q2 2025. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Cubist Systematic Strategies held 290,088 shares of Adaptive Biotechnologies worth $4.34M as of Q3 2025.
  • Cubist Systematic Strategies sold 168,783 Adaptive Biotechnologies shares in Q3 2025, an estimated $2.06M.
  • Adaptive Biotechnologies made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1049 holding.
  • Cubist Systematic Strategies first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 19 quarters since.
  • Cubist Systematic Strategies's Adaptive Biotechnologies position peaked at $5.35M in Q2 2025.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.